Publicacións en colaboración con investigadores/as de Harvard Medical School (27)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  3. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

    Nature Genetics, Vol. 55, Núm. 1, pp. 89-99

  4. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

    Gastroenterology

  5. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

    American Journal of Human Genetics, Vol. 110, Núm. 7, pp. 1200-1206

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  2. Viability Study of Machine Learning-Based Prediction of COVID-19 Pandemic Impact in Obsessive-Compulsive Disorder Patients

    Frontiers in Neuroinformatics, Vol. 16

2021

  1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

    Nature Communications, Vol. 12, Núm. 1

  2. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 4, pp. 623-642

  3. Breast cancer risk genes - Association analysis in more than 113,000 women

    New England Journal of Medicine, Vol. 384, Núm. 5, pp. 428-439

  4. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078))

    Nature communications

2020

  1. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

    Nature Communications, Vol. 11, Núm. 1

  2. Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e801-e806

2019

  1. Circulating metabolic biomarkers of screen-detected prostate cancer in the ProtecT study

    Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 1, pp. 208-216

  2. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

  3. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157

  4. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results

    Acta Diabetologica, Vol. 56, Núm. 12, pp. 1341-1350

  5. Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study

    Acta Diabetologica

2018

  1. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

    Nature Genetics, Vol. 50, Núm. 7, pp. 968-978

  2. Choroidal thickness in diabetic retinopathy assessed with swept-source optical coherence tomography

    Retina, Vol. 38, Núm. 1, pp. 173-182